Demis Hassabis Using Ai To Accelerate Scientific Discovery The Mit On a visit to cambridge in march 2025, sir demis hassabis who in 2024 became our first alumnus to receive a nobel prize gave this talk on 'accelerating scientific discovery with. Watch the full #gtc23 session at bit.ly 3mdq3lt demis hassabis, founder & ceo of @google deepmind, discusses how #ai is accelerating scientific progress on the world’s greatest.
Using Ai To Accelerate Scientific Discovery Demis Hassabis Crick I believe we are on the cusp of an exciting new era in science with ai poised to be a powerful tool for accelerating scientific discovery itself. we recently demonstrated this potential with our alphafold system, a solution to the 50 year grand challenge of protein structure prediction, culminating in the release of the most accurate and. In this lecture, he describes his journey from a child chess prodigy whose interest in computers was sparked by using them to improve his chess game, to his time at cambridge university to his ai career today. Started isomorphic labs to build on alphafold and reimagine the drug discovery process from first principles with ai (years to months) we sometimes think of this as doing science at digital speed. On a visit to cambridge in march 2025, sir demis hassabis – who in 2024 became our first alumnus to receive a nobel prize – gave this talk on ‘accelerating scientific discovery with ai’.
Demis Hassabis Using Ai To Accelerate Scientific Discovery R Singularity Started isomorphic labs to build on alphafold and reimagine the drug discovery process from first principles with ai (years to months) we sometimes think of this as doing science at digital speed. On a visit to cambridge in march 2025, sir demis hassabis – who in 2024 became our first alumnus to receive a nobel prize – gave this talk on ‘accelerating scientific discovery with ai’. The alphafold breakthrough led demis to found isomorphic labs in 2021, to apply ai and computational methods to drug discovery, making it possible to develop new targeted drugs faster than ever before. isomorphic labs is based in lausanne and london. The alphafold breakthrough led demis to found isomorphic labs in 2021, to apply ai and computational methods to drug discovery, making it possible to develop new targeted drugs faster than ever before. I believe we are on the cusp of an exciting new era in science with ai poised to be a powerful tool for accelerating scientific discovery itself. we recently demonstrated this potential with our alphafold system, a solution to the 50 year grand challenge of protein structure prediction, culminating in the release of the most accurate and.